专栏名称: 格隆汇
格隆汇旗下公众号。分享和探讨港股、美国中概股以及少量估值确有吸引力之A股的投资线索、投资机会与投资心得.
目录
相关文章推荐
51好读  ›  专栏  ›  格隆汇

【中英对照】历年汇总:巴菲特探讨各行各业投资心得(下)

格隆汇  · 公众号  · 财经  · 2017-03-10 20:48

正文

请到「今天看啥」查看全文



No, we’ve never done anything in healthcare.


是的,我们从来没有投资过医疗行业。


Source: BRK Annual Meeting 2006 Tilson Notes

URL:

Time: 2006



[Re: fixing the U.S. Healthcare System]

回复:修正美国医疗体系


Munger: It’s too tough. We can’t solve that one. We try to look for easy problems. We don’t try tough things. Sometimes life hands you a very tough problem you have to wrestle with – not financial problems for us, but personal ones.


查理芒格:这太难了,我们无法解决这个问题,我们想去解决的是简单的问题,不是这种难搞定的问题。有时候生活递给你一个十分艰难的问题,你必须去搏斗——对于我们来说这类问题不是财务上的问题,而是个人的问题。


If we were looking at a private-sector solution, we’d look for low distribution costs. You don’t want a lot of revenue soaked up in frictional costs, but I don’t know how to do that. If we’re paying 15% of GDP [for healthcare], you’d think someone would figure it out. Maybe this will come up in the upcoming presidential campaign.


如果我们在寻找一个私营部门的解决方案,我们会寻找低的分销成本。你不会愿意看到大量的盈利磨灭在摩擦成本里面,但我也不清楚要怎么才能做到。


Source: BRK Annual Meeting 2007 Tilson Notes

URL:

Time: 2007



[Re: Pharma? How do you value the pipeline of drug companies?]

回复:那制药行业呢?您怎么对制药公司正在研发的药品估值?


WB: Unlike many businesses, when we invest in pharma, we don’t know the answer on the pipeline, and it’ll be a different pipeline 5 years from now anyway. We don’t know whether Pfizer or Merck, etc, have a better chance, or which of those will come out with a blockbuster. But we do feel we have a group of companies bought at a fair price that, overall, will do well and should offer chances for decent profits. These companies are doing very important things. I could not tell you the potential in the pipeline. A group approach makes sense. It is not the way we would go at banks. If you buy pharma at a reasonable multiple, you will probably do okay 5-10 years from now.


沃伦:跟别的行业不一样,我们在投资制药行业时无法对其研发的药品下个结论,毕竟五年之后这个药品可能就大不相同了。我们也不知道Pfizer(瑞辉,美国制药公司)或者Merck(默克,美国制药公司)这些公司里面是不是存在更好的机会,还是这些企业会制作出下一个火爆市场的药品。不过我们能确定是,我们的的确确在合理的价格买入了一组制药公司,它们能够经营良好,并且提供了赚取良好回报的机会。这类公司做的业务都十分重要,我无法告诉你有潜力的药剂是什么。设置投资组合是有意义的,这跟我们对待银行也采取的方法不一样。如果你在合理的倍数下买入了制药公司,5-10年的收益率可能是很不错的。


Source: BRK Annual Meeting 2008 Boodell Notes

URL:

Time: 2008



Berkshire has invested in several insurance companies, would you go into the health insurance business?

伯克希尔投资了一些保险公司,您会投资一些医疗保险公司嘛?


No. Health insurance is so ingrained into national policy that it is a tough business. I’m not really that excited about it from a business perspective. I don’t want to write policies with high loan loss ratios. That being said, I would buy the stock of an undervalued healthcare insurer.


不会。医疗保险跟国家政策相关性太强了,所以这个行业并不好做。从商业的角度来看,我对这个行业并不感兴趣。我不希望提出贷款损失率很高的的条款。话虽如此,我还是会买入被低估的医疗保险股。


Source: Q&A with 6 Business Schools

URL:

Time: Feb 2009



What do you think of the telecoms industry?

您怎么看待通讯行业?







请到「今天看啥」查看全文